DocuSign price target lowered to $52 from $65 at UBS

UBS analyst Karl Keirstead lowered the firm’s price target on DocuSign to $52 from $65 and keeps a Neutral rating on the shares ahead of its Q3 results this week. The analyst is citing the risk of a guide-down in January quarter outlook.